Log In
Print
BCIQ
Print
Print this Print this
 

Saphris, Sycrest, asenapine (ME2136, SCH 900274)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionSerotonin (5-HT2) receptor and dopamine D2 receptor antagonist
Molecular Target Serotonin (5-HT2) receptor ; Dopamine D2 receptor
Mechanism of ActionDopamine receptor antagonist; Serotonin (5-HT) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today